Cargando…
Effects of luseogliflozin on estimated plasma volume in patients with heart failure with preserved ejection fraction
AIMS: Sodium glucose co‐transporter 2 inhibitors have diuretic effects in both patients with glycosuria and with natriuresis. We sought to assess the effect of luseogliflozin on estimated plasma volume (ePV) in patients with type 2 diabetes and heart failure with preserved ejection fraction (HFpEF)....
Autores principales: | Nakashima, Mitsutaka, Miyoshi, Toru, Ejiri, Kentaro, Kihara, Hajime, Hata, Yoshiki, Nagano, Toshihiko, Takaishi, Atsushi, Toda, Hironobu, Nanba, Seiji, Nakamura, Yoichi, Akagi, Satoshi, Sakuragi, Satoru, Minagawa, Taro, Kawai, Yusuke, Nishii, Nobuhiro, Fuke, Soichiro, Yoshikawa, Masaki, Nakamura, Kazufumi, Ito, Hiroshi, Namba, Seiji, Sato, Tetsuya, Sugiyama, Hiroyasu, Imai, Michio, Gotoh, Naoki, Segawa, Tomonori, Noda, Toshiyuki, Koshiji, Masatoshi, Kajikawa, Yutaka, Morita, Hiroshi, Yoshida, Masashi, Doi, Masayuki, Oka, Takafumi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8787977/ https://www.ncbi.nlm.nih.gov/pubmed/35267246 http://dx.doi.org/10.1002/ehf2.13683 |
Ejemplares similares
-
Effect of Luseogliflozin on Heart Failure With Preserved Ejection Fraction in Patients With Diabetes Mellitus
por: Ejiri, Kentaro, et al.
Publicado: (2020) -
Effects of luseogliflozin and voglibose on high-risk lipid profiles and inflammatory markers in diabetes patients with heart failure
por: Ejiri, Kentaro, et al.
Publicado: (2022) -
The effect of luseogliflozin and alpha-glucosidase inhibitor on heart failure with preserved ejection fraction in diabetic patients: rationale and design of the MUSCAT-HF randomised controlled trial
por: Ejiri, Kentaro, et al.
Publicado: (2019) -
Nanoparticle-Mediated Drug Delivery System for Pulmonary Arterial Hypertension
por: Nakamura, Kazufumi, et al.
Publicado: (2017) -
Combination of Renal Angioplasty and Angiotensin-converting-enzyme Inhibitor Can Reduce Proteinuria in Patients with Bilateral Renal Artery Disease
por: Toda, Hironobu, et al.
Publicado: (2019)